UBS Group’s Healthcare AI Acquisition Corp. Class A Ordinary Shares HAIA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-500
Closed -$5.57K 10287
2024
Q2
$5.57K Buy
+500
New +$5.56K ﹤0.01% 7976
2023
Q4
Sell
-1
Closed -$11 10087
2023
Q3
$11 Buy
+1
New +$11 ﹤0.01% 9206
2023
Q2
Sell
-2,100
Closed -$21.9K 9874
2023
Q1
$21.9K Buy
+2,100
New +$21.7K ﹤0.01% 7018
2022
Q4
Sell
-643
Closed -$6K 11278
2022
Q3
$6K Buy
+643
New +$6.43K ﹤0.01% 9092

Other funds holding HAIA

UBS Group's HAIA Position: Q3 2024 in Review

UBS Group sold out of Healthcare AI Acquisition Corp. Class A Ordinary Shares (HAIA) in Q3 2024, closing a stake of 500 shares — an estimated $5.57K sold.

UBS Group first reported a position in HAIA in Q3 2022 and held it in 4 quarters. The position peaked at $21.9K in Q1 2023. 9 funds tracked by Wall St. Rank hold HAIA as of Q3 2024.

  • UBS Group reported no remaining Healthcare AI Acquisition Corp. Class A Ordinary Shares position as of Q3 2024 after selling out during the quarter.
  • UBS Group sold 500 Healthcare AI Acquisition Corp. Class A Ordinary Shares shares in Q3 2024, an estimated $5.57K.
  • UBS Group first reported a position in Healthcare AI Acquisition Corp. Class A Ordinary Shares in Q3 2022 and held it in 4 quarters.
  • UBS Group's Healthcare AI Acquisition Corp. Class A Ordinary Shares position peaked at $21.9K in Q1 2023.
  • 9 funds tracked by Wall St. Rank held Healthcare AI Acquisition Corp. Class A Ordinary Shares as of Q3 2024.

Based on UBS Group's 13F filing for Q3 2024, filed 14 Nov 2024.